Laboratory News and Research

RSS

Cranberry juice doesn’t affect every woman the same way

Cranberry juice's effectiveness against UTIs varies among women due to metabolic differences, impacting urinary anti-adhesion activity and pathogen response.

6 Oct 2026

Tau modifications shape filament structures in neurodegenerative diseases

In neurodegenerative diseases such as Alzheimer's disease, progressive neuronal damage is associated with the accumulation of abnormal tau filaments in the brain.

6 Oct 2026

One Health approach could improve India’s response to mycetoma

A 60-year-old Indian farmer developed two infections—one in his foot following an injury from a cow's hoof, the other in his buttock after a thorn prick in the fields three years later.

5 Oct 2026

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, and Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the launch of AFT-70 NAVIGATE, a randomized phase III trial evaluating a novel molecular residual disease (MRD)-guided treatment strategy for patients with intermediate and high-risk ER-positive/HER2-negative early breast cancer.

5 Oct 2026

Lipid signaling pathway helps cells survive bacterial toxin damage

Epithelial cells form the body's frontline barriers, helping keep microbes, toxins, and other harmful substances out.

5 Oct 2026

New model predicts growth hormone therapy response in children with short stature

Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for their age and sex without any identifiable medical cause.

5 Oct 2026

New study investigates PFAS exposure and future inflammatory bowel disease

Exposure to per- and polyfluoroalkyl substances (PFAS), often called "forever chemicals," may play a role in the development of inflammatory bowel disease (IBD) years before symptoms appear, according to a new five-year study supported by a $3.3 million National Institutes of Health (NIH) R01 grant to researchers at the Icahn School of Medicine at Mount Sinai.

5 Oct 2026

Restoring cellular recycling helps the body clear harmful zombie cells

As we grow older, our bodies accumulate "zombie cells"-living cells that have stopped dividing or functioning normally-but linger in our tissues, contributing to chronic inflammation and age-related diseases.

5 Oct 2026

Many herbal toothpastes fell short on a key cavity-fighting ingredient

A study on herbal toothpastes reveals varying fluoride levels, antibacterial efficacy, and cytotoxicity, highlighting safety concerns in oral hygiene products.

5 Oct 2026

Poor nutrition scores predict mortality risk beyond body weight

In a population-based cohort of 8,398 adults in Leipzig, Germany, poorer nutritional status measured using several laboratory-based scores was associated with a higher risk of all-cause mortality over a median follow-up of about 7.5 years.

5 Oct 2026

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

Tirzepatide cuts body fat while preserving skeletal muscle in real-world study

2 Oct 2026

$Vitamin B12 deficiency was linked to higher fracture hazard after 50$

Vitamin B12 deficiency was linked to higher fracture hazard after 50

A study links abnormal vitamin B12 levels to fracture risk, highlighting a complex relationship beyond simple deficiency in middle-aged and older adults.

2 Oct 2026

New strategy uncovers bioactive compounds from fragmented metagenomic data

Researchers have developed a practical strategy for recovering biosynthetic information from fragmented metagenomic data.

1 Oct 2026

Ultrasensitive AMH testing offers new insights into midlife ovarian reserve

In women's lifelong health management, the years from 35 to 55 form a critical transition period. During this period, many women face a triple challenge: declining fertility, bothersome perimenopausal symptoms, and delayed or delays in recognizing or confirming menopause.

1 Oct 2026

Portable paper device rapidly detects scopolamine in beverages

Isabel Poves, researcher at the University of the Basque Country-EHU, has developed a microfluidic paper-based device that provides a rapid, reliable and easy way to detect scopolamine and related compounds.

1 Oct 2026

Type 1 diabetes incidence rose by 11% after rotavirus vaccine rollout in Norway

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in Diabetologia (the journal of EASD) shows that incidence (the new case rate) of type 1 diabetes (T1D) in children aged 0.5-5 years in Norway was 11% higher following the rapid roll out and uptake of the rotavirus vaccine in September 2014.

1 Oct 2026